European carmakers are urging Brussels to ease regulations to help them avoid buying carbon credits from rivals at increasingly high prices.
Category: China
-
Tesla’s Profit Fell Sharply Last Year
The electric car company run by Elon Musk is facing increasing competition, but investors have focused mostly on the prospects for Tesla’s self-driving technology.
-
Who Is Liang Wenfeng, the Founder of A.I. Start-Up DeepSeek?
The Chinese company DeepSeek seemed to have come out of nowhere this week when it upturned markets. Here’s what to know about the engineer who started it.
-
Leaving the W.H.O. Could Hurt Americans on a Range of Health Matters
President Trump’s decision to pull out of the international health agency could deprive the United States of crucial scientific data and lessen the country’s influence in setting a global health agenda.
-
Do DeepSeek’s A.I. Advances Mean US Tech Controls Have Failed?
DeepSeek’s A.I. models show that China is making rapid gains in the field, despite American efforts to hinder it.
-
How China Is Reacting to DeepSeek Upending the A.I. Race
Social media exploded in a celebration after the news that a Chinese start-up had made an artificial intelligence tool that was more efficient than any in the United States.
-
How DeepSeek Went From Stock Trader to A.I. Star
The little-known artificial intelligence firm has emphasized research, even as it emerged as the brainchild of a hedge fund.
-
G.M. Has Plans Ready for Trump’s Canada and Mexico Tariffs
General Motors, the largest producer of cars in Mexico, won’t provide details on how it would react if President Trump imposes 25 percent tariffs from the two countries.
-
China Vanke Forecasts $6.2 Billion Loss, Replaces Top Executives
China Vanke, one of the country’s largest developers, cleared out its top executives and said it anticipates a $6.2 billion loss, a sign the property meltdown is still raging.
-
In China, Government Data on Drugs Blocked From Public After Backlash
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine.
-
In China, Rare Dissent Over a Program to Save on Drug Costs
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.